Literature DB >> 7867791

'Brain-type' N-glycosylation of asialo-transferrin from human cerebrospinal fluid.

A Hoffmann1, M Nimtz, R Getzlaff, H S Conradt.   

Abstract

Asialo-transferrin from human cerebrospinal fluid was purified to homogeneity. Investigation of the structural characteristics of its oligosaccharides support our hypothesis of 'brain-type' glycosylation of intrathecally synthesized cerebrospinal fluid proteins. For carbohydrate structural analysis, high-pH anion-exchange chromatography, methylation analysis, liquid secondary ion- and matrix-assisted laser desorption/ ionization mass spectrometry of the permethylated derivatives were used. The major structure turned out to be a complex-type agalactodiantennary oligosaccharide with bisecting N-acetylglucosamine and proximal fucose. Analysis of a second transferrin preparation containing both asialo- and sialo-transferrin revealed another major glycan species derived from the sialylated transferrin variant which is galactosylated and lacks bisecting N-acetylglucosamine and fucose.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7867791     DOI: 10.1016/0014-5793(95)00034-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Characterization of Transferrin Glycopeptide Structures in Human Cerebrospinal Fluid.

Authors:  Kristy J Brown; Adeline Vanderver; Eric P Hoffman; Raphael Schiffmann; Yetrib Hathout
Journal:  Int J Mass Spectrom       Date:  2012-02-15       Impact factor: 1.986

Review 2.  Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells.

Authors:  E Grabenhorst; P Schlenke; S Pohl; M Nimtz; H S Conradt
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

3.  Characterization of symmetric complexes of nerve growth factor and the ectodomain of the pan-neurotrophin receptor, p75NTR.

Authors:  Jukka P Aurikko; Brandon T Ruotolo; J Günter Grossmann; Martin C Moncrieffe; Elaine Stephens; Veli-Matti Leppänen; Carol V Robinson; Mart Saarma; Ralph A Bradshaw; Tom L Blundell
Journal:  J Biol Chem       Date:  2005-07-11       Impact factor: 5.157

4.  Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.

Authors:  David E Connor; Ganta V Chaitanya; Prashant Chittiboina; Paul McCarthy; L Keith Scott; Lisa Schrott; Alireza Minagar; Anil Nanda; J Steven Alexander
Journal:  Pathophysiology       Date:  2017-05-13

5.  Changes in concanavalin A-reactive proteins in neurological disorders.

Authors:  L Saso; G Valentini; M G Leone; E Grippa; R Guglielmi; L Paris; G Cantore; B Silvestrini
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

6.  Comparison of lectin-binding patterns between young adults and older rat glycoproteins in the brain.

Authors:  Y Sato; M Kimura; T Endo
Journal:  Glycoconj J       Date:  1998-12       Impact factor: 2.916

7.  Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation.

Authors:  P Mills; K Mills; P Clayton; A Johnson; D Whitehouse; B Winchester
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

8.  Recognition of bisecting N-acetylglucosamine: structural basis for asymmetric interaction with the mouse lectin dendritic cell inhibitory receptor 2.

Authors:  Masamichi Nagae; Kousuke Yamanaka; Shinya Hanashima; Akemi Ikeda; Kana Morita-Matsumoto; Tadashi Satoh; Naoki Matsumoto; Kazuo Yamamoto; Yoshiki Yamaguchi
Journal:  J Biol Chem       Date:  2013-10-09       Impact factor: 5.157

9.  Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.

Authors:  A Vanderver; Y Hathout; J Maletkovic; E S Gordon; M Mintz; M Timmons; E P Hoffman; L Horzinski; F Niel; A Fogli; O Boespflug-Tanguy; R Schiffmann
Journal:  Neurology       Date:  2008-06-03       Impact factor: 9.910

Review 10.  Glycosylation Changes in Brain Cancer.

Authors:  Lucas Veillon; Christina Fakih; Hadi Abou-El-Hassan; Firas Kobeissy; Yehia Mechref
Journal:  ACS Chem Neurosci       Date:  2017-11-07       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.